Alcon Launches SYSTANE® COMPLETE Preservative-Free Lubricant Eye Drops in Canada

Alcon announced the Canadian launch of the newest addition to its innovative portfolio of dry eye products. New SYSTANE® COMPLETE Preservative-Free Lubricant Eye Drops is an all-in-one solution available in an easy-to-use, multi-dose bottle.

According to the press release, the SYSTANE® COMPLETE Preservative-Free formula works for all types of dry eye, hydrating and protecting with one drop. Alcon’s proprietary, nano-droplet technology allows for fast-acting hydration, tear evaporation protection, and long-lasting relief for a patient’s eyes.

“We’re thrilled to introduce SYSTANE® COMPLETE Preservative-Free to the Canadian market,” said Chris Gruhn, General Manager of Alcon Canada. “Research shows that 86 percent of dry eye sufferers have some form of evaporative dry eye yet most eye drops are not designed to address it. For those with dry eye symptoms but unclear on what type of dry eye they have, SYSTANE® COMPLETE Preservative-Free can help as it has been clinically demonstrated to provide all day* symptom relief for all types of dry eye, hydrating and protecting with one drop.”

Moreover, in a long-term clinical trial, dry eye patients using SYSTANE® COMPLETE four times daily for 6 months experienced a statistically and clinically significant improvement in symptom scores. Additionally, 20% of patients treated with SYSTANE® COMPLETE no longer met the criteria that optometrists use to diagnose dry eye.

Click HERE for the full press release.

Featured Posts

Transitions and the OAC Now Accepting Applications for the 2023 Students of Vision Scholarship Program

This year students will be asked to discuss the importance on diversity and multicultural efforts in eyecare.

Learn More

Karen Walsh Appointed to Lead CooperVision Global Professional Affairs

Full Scope Approach Reflects Global Growth and ECP-Centric Focus

Read more

Lightec, Where the Lightness is Paramount

While the comfort and the lightness are at the heart of Lightec's philosophy, the design is never compromised.

Read more

Using Gene Therapy to Treat Genetic Eye Disease Aniridia

In 2020, Fighting Blindness Canada awarded Dr. Elizabeth Simpson at the University of British Columbia a research grant of $297,000 to support the development of a potential gene therapy for the inherited eye disease, aniridia.

Read more

Winners of the 30th SILMO d’Or

And here are the winners!

Read more

Transitions and the OAC Now Accepting Applications for the 2023 Students of Vision Scholarship Program

This year students will be asked to discuss the importance on diversity and multicultural efforts in eyecare.

Learn More

Karen Walsh Appointed to Lead CooperVision Global Professional Affairs

Full Scope Approach Reflects Global Growth and ECP-Centric Focus

Read More

Lightec, Where the Lightness is Paramount

While the comfort and the lightness are at the heart of Lightec's philosophy, the design is never compromised.

Read More

Using Gene Therapy to Treat Genetic Eye Disease Aniridia

In 2020, Fighting Blindness Canada awarded Dr. Elizabeth Simpson at the University of British Columbia a research grant of $297,000 to support the development of a potential gene therapy for the inherited eye disease, aniridia.

Read More

Winners of the 30th SILMO d’Or

And here are the winners!

Read More

Transitions and the OAC Now Accepting Applications for the 2023 Students of Vision Scholarship Program

This year students will be asked to discuss the importance on diversity and multicultural efforts in eyecare.

Learn More

Karen Walsh Appointed to Lead CooperVision Global Professional Affairs

Full Scope Approach Reflects Global Growth and ECP-Centric Focus

Read more

Lightec, Where the Lightness is Paramount

While the comfort and the lightness are at the heart of Lightec's philosophy, the design is never compromised.

Read more

Using Gene Therapy to Treat Genetic Eye Disease Aniridia

In 2020, Fighting Blindness Canada awarded Dr. Elizabeth Simpson at the University of British Columbia a research grant of $297,000 to support the development of a potential gene therapy for the inherited eye disease, aniridia.

Read more

Winners of the 30th SILMO d’Or

And here are the winners!

Read more

Transitions and the OAC Now Accepting Applications for the 2023 Students of Vision Scholarship Program

This year students will be asked to discuss the importance on diversity and multicultural efforts in eyecare.

Learn More

Karen Walsh Appointed to Lead CooperVision Global Professional Affairs

Full Scope Approach Reflects Global Growth and ECP-Centric Focus

Read more

Lightec, Where the Lightness is Paramount

While the comfort and the lightness are at the heart of Lightec's philosophy, the design is never compromised.

Read more

Using Gene Therapy to Treat Genetic Eye Disease Aniridia

In 2020, Fighting Blindness Canada awarded Dr. Elizabeth Simpson at the University of British Columbia a research grant of $297,000 to support the development of a potential gene therapy for the inherited eye disease, aniridia.

Read more

Winners of the 30th SILMO d’Or

And here are the winners!

Read more